Hemp News Today — July 24, 2026
Can state-regulated hemp THC businesses continue under Schedule 1? and more — today's hemp signal.
As the hemp and cannabis industries continue to evolve, questions surrounding regulation and compliance remain at the forefront. The ongoing debate about the classification of hemp-derived THC products under Schedule 1 has left many businesses uncertain about their future operations. With the hemp industry growing rapidly, it is crucial to address these concerns and provide clarity on the regulatory framework. Meanwhile, in Georgia, the medical cannabis industry has experienced significant growth since the state implemented reforms, demonstrating the potential for expansion and development in the sector.
The success of the medical cannabis industry in Georgia serves as a model for other states, highlighting the importance of effective regulation and support for businesses. As the industry expands, entrepreneurs and investors are taking notice, with some notable figures making significant bets on the future of cannabis. For example, a cannabis CEO who oversaw a $2.1 billion sale is now investing in smaller, emerging companies, indicating a shift towards more targeted and strategic growth. As the hemp and cannabis industries navigate the complexities of regulation and growth, it is essential to stay informed about the latest developments and trends, and to consider the potential implications for businesses and consumers alike.
Today's signal:
• Can state-regulated hemp THC businesses continue under Schedule 1? (mjbizdaily.com)
• Rapid growth for Georgia medical cannabis industry since reform (mjbizdaily.com)
• The cannabis CEO behind a $2.1 billion sale bets again, but smaller (mjbizdaily.com)